Chemoinformaics analysis of 3-Methoxybutyl acetate
| Molecular Weight | 146.186 | nRot | 4 |
| Heavy Atom Molecular Weight | 132.074 | nRig | 10 |
| Exact Molecular Weight | 146.094 | nRing | 0 |
| Solubility: LogS | -4.356 | nHRing | 0 |
| Solubility: LogP | 3.786 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 23.4311 |
| nHD | 0 | BPOL | 18.3849 |
| QED | 0.504 |
| Synth | 4.381 |
| Natural Product Likeliness | 2.609 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.505 |
| Pgp-sub | 0.002 |
| HIA | 0.006 |
| CACO-2 | -4.575 |
| MDCK | 0.0000234 |
| BBB | 0.212 |
| PPB | 0.754043 |
| VDSS | 1.763 |
| FU | 0.177733 |
| CYP1A2-inh | 0.133 |
| CYP1A2-sub | 0.644 |
| CYP2c19-inh | 0.397 |
| CYP2c19-sub | 0.898 |
| CYP2c9-inh | 0.095 |
| CYP2c9-sub | 0.21 |
| CYP2d6-inh | 0.311 |
| CYP2d6-sub | 0.526 |
| CYP3a4-inh | 0.674 |
| CYP3a4-sub | 0.526 |
| CL | 9.45 |
| T12 | 0.215 |
| hERG | 0.01 |
| Ames | 0.009 |
| ROA | 0.471 |
| SkinSen | 0.201 |
| Carcinogencity | 0.573 |
| EI | 0.527 |
| Respiratory | 0.968 |
| NR-Aromatase | 0.017 |
| Antiviral | No |
| Prediction | 0.954256 |